McGowan Institute for Regenerative Medicine

Artificial Liver

The McGowan Institute is developing an artificial liver — composed of both synthetic materials and live liver cells — that can filter blood like a natural liver. This device is designed to sustain a patient until a donor organ is available, or unburden the liver for a time so that it can heal. In an early clinical research study, 80 percent of those treated with the artificial liver survived until a donor organ was found or recovered liver function. The artificial liver is now being prepared for the next stage of clinical studies.

In this Section

Artificial Heart and
Ventricular Assist Devices

Heart assist devices help keep patients – and hope – alive.

Artificial Liver
Patients with failing livers need
a bridge to transplant, too.

Artificial Lung
We can't survive without oxygen.

The UPMC Clinical Artificial
Heart Program

One of the world's largest and most experienced programs
of its kind.